SCHEMBL613348

SCHEMBL613348

CCC1(C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756962 1.00 — —
Hydrogen Sulfide SCHEMBL5678752 0.96 — —
SCHEMBL8050124 0.96 — —
Ammonia Solution, Strong SCHEMBL354382 0.96 — —
SCHEMBL23655465 0.89 KDM4E (0.36) —
SCHEMBL8052471 0.87 KDM4E (0.35) —
SCHEMBL2289717 0.85 — —
SCHEMBL597791 0.85 — —
SCHEMBL22641360 0.84 KDM4E (0.33) —
SCHEMBL16119813 0.84 KDM4E (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2829555-B1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS INC (JP) 2018-05-16 — — EP claimed
EP-3089980-B1 SERINE/THREONINE KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2018-01-31 — — EP claimed
US-9670208-B2 Serine/threonine kinase inhibitors ARRAY BIOPHARMA INC. (US) 2017-06-06 — — US claimed
US-20160304519-A1 SERINE/THREONINE KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2016-10-20 — — US claimed
CN-104203993-B Process for producing olefin polymer 三井化学株式会社 2016-06-15 — — CN claimed
EP-2483531-A2 A HEAT RECOVERY SYSTEM BASED ON THE USE OF A STABILIZED ORGANIC RANKINE FLUID, AND RELATED PROCESSES AND DEVICES General Electric Company (US) 2012-08-08 — — EP claimed
US-20110072819-A1 HEAT RECOVERY SYSTEM BASED ON THE USE OF A STABILIZED ORGANIC RANKINE FLUID, AND RELATED PROCESSES AND DEVICES GENERAL ELECTRIC COMPANY (US) 2011-03-31 — — US claimed
WO-2011037709-A2 A HEAT RECOVERY SYSTEM BASED ON THE USE OF A STABILIZED ORGANIC RANKINE FLUID, AND RELATED PROCESSES AND DEVICES GENERAL ELECTRIC COMPANY (US) 2011-03-31 — — WO claimed
US-20090306442-A1 OLIGOMERISATION CATALYST WITH PENDANT DONOR GROUPS SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2009-12-10 — — US claimed
EP-2024305-A2 OLIGOMERISATION CATALYST WITH PENDANT DONOR GROUPS Sasol Technology (Pty) Ltd (ZA) 2009-02-18 — — EP claimed
WO-2007138545-A2 OLIGOMERISATION CATALYST WITH PENDANT DONOR GROUPS SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2007-12-06 — — WO claimed
CN-112543764-B Amide compound with BET proteolytic induction effect and medical application thereof 田边三菱制药株式会社 2024-05-10 — — CN disclosed
US-20230339884-A1 Triazole N-Linked Carbamoyl Cyclohexyl Acids as LPA Antagonists BRISTOL MYERS SQUIBB CO (US) 2023-10-26 — — US disclosed
US-11697646-B2 Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2023-07-11 — — US disclosed
EP-3810283-B1 SOLID FORMS OF THE TARTRATE SALT OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL, PROCESS FOR THEIR PREPARATION AND METHODS OF THEIR USE IN TREATING CANCERS HOFFMANN LA ROCHE (CH) 2023-06-14 — — EP disclosed
WO-2003032910-A2 CARBINOLS FOR THE TREATMENT OF NEUROPATHIC DYSFUNCTION ENDO PHARMACEUTICALS INC. (US) 2003-04-24 — — WO disclosed
EP-1289944-A2 THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 Atherogenics, Inc. (US) 2003-03-12 — — EP disclosed
EP-1213281-A1 NOVEL AMIDE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 — — EP disclosed
US-20020016300-A1 Thioketals and thioethers for inhibiting the expression of VCAM-1 CRABTREE ACQUISITION CO, LLC 2002-02-07 — — US disclosed
WO-2001070757-A2 THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 ATHEROGENICS, INC. (US) 2001-09-27 — — WO disclosed
Send feedback